Intermittent fasting with immunotherapy for advanced cancers
Part of Cancer, Digestive system, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial studies whether intermittent fasting (eating only during certain hours) can make immunotherapy treatment work better or cause fewer side effects in people with certain advanced cancers. If you can safely fast, this could be a way to boost your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer of the esophagus, stomach, lung, liver, bile duct, skin (melanoma), kidney, or a cancer with MSI-H (a genetic marker that often responds well to immunotherapy).
- Your treatment plan includes immunotherapy (also called checkpoint inhibitors).
- You are able to carry out daily activities with little or no help (performance status 0–2).
- Your body mass index (BMI) is between 23 and 40.
- You are willing to follow a fasting (eating time-restricted) diet and write down how well you stick to it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a high-fiber diet and occasional short-term fasting can help melanoma patients respond better to immunotherapy. It aims to improve treatment outcomes by changing gut health.
This trial studies whether a 14-hour night fast and 10-hour eating window can improve inflammation markers and quality of life in women with HR+/HER2- early breast cancer. You would start the fasting routine within three months of beginning hormone therapy.
This study combines a special periodic diet that mimics fasting with the standard immunotherapy drug pembrolizumab (Keytruda) for people with advanced non-small cell lung cancer. The goal is to see if the diet can help the immunotherapy work better.
This trial tests whether intermittent fasting (alternating between eating and not eating for certain periods) can help men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). It aims to see if fasting during treatment can reduce side effects or improve how well the therapy works.
This pilot study tests whether alternating periods of lower calorie intake, along with a plant-based diet, is safe and feasible for people receiving chemotherapy. If it helps, it could support better comfort and treatment tolerance during cancer therapy.
This trial tests whether alternating between a fasting day and a normal eating day can help people recovering from gynecologic cancer surgery while they receive chemotherapy. It aims to see if this eating pattern is safe and helpful during treatment.
Hear when a new Cancer (Advanced Stage) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.